Dr. Jennifer Beecker
Dr. Beecker is a Staff Dermatologist at The Ottawa Hospital and Assistant Professor at The University of Ottawa. She is a Royal College and American Board of Dermatology certified dermatologist, trained and certified in 3 medical specialties: Dermatology, Emergency Medicine and Family Medicine.
Dr. Beecker is the Research Director for the Division of Dermatology at The Ottawa Hospital. She is the President-Elect of the CDA Board of Directors and Past-National Chair and Spokesperson for the Canadian Dermatology Association’s Sun Awareness Program. Dr. Beecker trains medical residents and students and is incoming Vice-Chair for the Royal College of Physicians and Surgeons Dermatology Examination.
Friday NOV 12, 2021
Emerging Oral Therapies for the Treatment of Moderate-to-Severe Psoriasis
This presentation will describe the unmet needs of patients with moderate-to-severe psoriasis and present the latest phase III trials data of emerging targeted oral options (TYK2 inhibitors). It will include interactivity, notably polling questions, a case study, and practical tips.
- Define the existing unmet needs for patients with moderate-to-severe psoriasis and discuss the potential role for emerging targeted oral options o Differentiate the mechanism of action of JAK inhibitors and TYK2 inhibitors
- Review the clinical relevance of the efficacy and safety data for TYK2 inhibitors
- Identify where TYK2 inhibitors fit in treating moderate-to-severe psoriasis